Lin Yee Chen, MD, MS

Associate Professor of Medicine, Cardiovascular Division

Lin Yee Chen

Contact Info

Office Address:
Cardiovascular Division
Variety Club Research Center
401 East River Parkway
2nd Floor
Minneapolis, Minnesota 55455

Mailing Address:
UMN – Cardiovascular Division
420 Delaware Street SE
MMC 508 Mayo
8508A (Campus Delivery Code)
Minneapolis, MN 55455

Administrative Assistant Name
Wendy

Administrative Phone
612-625-4401

Administrative Email
marku002@umn.edu

Administrative Fax Number
612-626-4411

Associate Professor of Medicine, Cardiovascular Division

Co-Director, Atrial Fibrillation Center, University of Minnesota Health Heart Care

Medical Director, Cardiac Electrophysiology Laboratory, University of Minnesota Medical Center

Chair, 2018 AHA Scientific Statement Writing Group: Atrial Fibrillation Burden—Moving Beyond Atrial Fibrillation as a Binary Entity


Cardiac Electrophysiologist, Cardiologist


Medical School, National University of Singapore, Singapore

Internal Medicine Residency, Mayo Clinic, Rochester, MN

Cardiology and Cardiac Electrophysiology Fellowship, Mayo Clinic, Rochester, MN

Master of Science in Clinical Research, University of Minnesota, Minneapolis, MN

Summary

I am a tenured Associate Professor of Medicine, an ABIM board-certified cardiac electrophysiologist, and an NIH-funded clinical investigator. My research on atrial fibrillation (AF) is focused on 2 themes: (1) To discover novel strategies to prevent AF, reduce AF burden, and prevent AF-related outcomes, and (2) To characterize the relationship of AF to outcomes such as stroke, dementia, and sudden cardiac death, and to elucidate the underlying mechanisms. As an Atherosclerosis Risk in Communities (ARIC) and Multi-Ethnic Study of Atherosclerosis (MESA) investigator, I have published and co-authored numerous papers on AF using ARIC and MESA data. Currently, I am the PI of 2 NIH R01-funded projects: (1) a large multi-center project (R01HL126637) that uses the Zio XT Patch—an ambulatory heart rhythm monitor—to define the prevalence of subclinical AF in the elderly and elucidate the prognostic significance of subclinical AF and AF burden, (2) R01HL141288 which aims to clarify the role of underlying left atrial abnormality in determining AF-related related stroke and cognitive decline. Clinically, I provide comprehensive, evidence-based, and state-of-the-art care to patients with AF which includes performing catheter ablation to maintain sinus rhythm and left atrial appendage occlusion to prevent cardioembolic stroke.

Awards & Recognition

  • American Heart Association, 10SDG3420031, 2010-2015, Gene-Gene and Gene-Environment Interactions in Atrial Fibrillation
  • National Institute on Aging, R21AG042660, 2013-2016, Arterial Structure and Function and Atrial Fibrillation
  • National Heart, Lung, and Blood Institute, R01HL126637, 2016-2021, Significance of Atrial Fibrillation and Atrial Fibrillation Burden Detected by Novel ECG Monitoring in Community-Dwelling Elderly
  • AHC Faculty Research Development Award, 2017-2019, Moderate-Intensity Continuous Training and Sprint Interval Training in Reducing Atrial Fibrillation Burden
  • National Heart, Lung, and Blood Institute, R01HL141288, 2018-2022, Left Atrial Abnormality and Atrial Fibrillation-Related Cerebral Infarcts and Cognitive Decline

Professional Associations

  • Member - Management Committee, Cardiovascular Service Line, University of Minnesota Health Heart Care
  • Member - ECG & Arrhythmias Committee, Clinical Cardiology Council, American Heart Association
  • Member - Research Committee, Heart Rhythm Society
  • Member - Evidence Review Committee for the AHA/ACC 2016 Guideline for the Treatment of Syncope
  • Member - 2017 ACC/AHA/Heart Rhythm Society Guideline Focused Update on the Management of Patients With Atrial Fibrillation Writing Committee
  • Member - 2018 EHRA/HRS/APHRS/SOLAECE Expert Consensus on Arrhythmias and Cognitive Function: What is the best practice?

Research

Research Summary/Interests

Care Philosophy
I believe in providing comprehensive and evidence-based cardiac electrophysiology care to my patients.

Research Funding Grants

Principal Investigator

  • NIH R01 HL126637 (2016-2021): Significance of Atrial Fibrillation and Atrial Fibrillation Burden Detected by Novel ECG Monitoring in Community-Dwelling Elderly
  • NIH R01 HL141288 (2018-2022): Left Atrial Abnormality and Atrial Fibrillation-Related Cerebral Infarcts and Cognitive Decline
  • Academic Health Faculty Research Development Grant (2017-2019): Moderate-Intensity Continuous Training and Sprint Interval Training in Reducing Atrial Fibrillation Burden

Co-Investigator

  • NIH R01 HL127659 (2015-2019): Atrial fibrillation burden, vascular disease of the brain and cardiac MRI in MESA
  • NIH R01 HL122200 (2015-2018): Comparative Effectiveness of Oral Anticoagulants in Atrial Fibrillation
  • NIH R21 AG058445 (2017-2019): Atrial fibrillation treatment in older adults

Clinical

Clinics

University of Minnesota Medical Center;University of Minnesota Physicians Heart at Fairvie

Board Certifications

  • Internal Medicine
  • Cardiology
  • Cardiac Electrophysiology

Clinical Interests

Atrial fibrillation ablation (pulmonary vein isolation); Biventricular ICD implantation; ICD implantation; PVC ablation; Supraventricular tachycardia ablation; Ventricular tachycardia ablation

Hospital Privileges

Fairview Lakes Medical Center; University of Minnesota Health Maple Grove Clinics; Fairview Ridges Hospital; Fairview Southdale Hospital; University of Minnesota Medical Center